As a senior member of Sg2’s service line thought leadership team, Jayme draws on her experiences working with health system and service line leaders to develop key insights for Sg2’s Life Sciences and Industry members. She supports client needs across a broad range of service line initiatives, including structuring, strategic planning, workforce alignment, technology adoption and care delivery innovation. Jayme is an esteemed thought leader in care at home, behavioral health and the neurosciences; while working on-site with clients, she has lead assessments that guide prioritization of program development and investment in these critical services.
During her 21-year tenure within Sg2’s Intelligence delivery team, Jayme has developed the initial content for many service lines and topic areas, including care at home, behavioral health, neurosciences, women’s health, surgical services and post-acute care. She is a seasoned speaker regularly appearing in Sg2’s Executive Summit conference series, Sg2 Webinars and has been invited to speak at national conferences on both neurosciences and behavioral health topics. She has been a keynote speaker at Medtronic’s Neurosciences Summit, NERVEs, BRAINs and the Ambulatory Association of Behavioral Health.
Before joining Sg2, Jayme worked with Technomic International’s pharmaceutical group and Abbott Laboratories’ drug-coated stent program. These experiences extended her field of expertise to include drug development, marketing and regulatory issues.
As a part of her master’s and doctoral work at Columbia University, Jayme studied and researched the molecular mechanism of disease. Her examination of basic cellular function can be applied to numerous diseases, including diabetes, Alzheimer disease, viral and bacterial infections, and cystic fibrosis.
Jayme remained at Columbia University as a National Institutes of Health–funded postdoctoral fellow to research the function of neuronal proteins—molecules implicated in numerous diseases. In her postdoctoral training at the University of Chicago, she examined the role of presenilin in Alzheimer disease. Jayme has a BS in chemistry from the Colorado School of Mines.